Cargando…

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

BACKGROUND: Inflammatory mediator prostaglandin E2–prostaglandin E2 receptor EP3 (PTGER3) signaling is critical for tumor-associated angiogenesis, tumor growth, and chemoresistance. However, the mechanism underlying these effects in ovarian cancer is not known. METHODS: An association between higher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez-Aguayo, Cristian, Bayraktar, Emine, Ivan, Cristina, Aslan, Burcu, Mai, Junhua, He, Guangan, Mangala, Lingegowda S., Jiang, Dahai, Nagaraja, Archana S., Ozpolat, Bulent, Chavez-Reyes, Arturo, Ferrari, Mauro, Mitra, Rahul, Siddik, Zahid H., Shen, Haifa, Yang, Xianbin, Sood, Anil K., Lopez-Berestein, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411965/ https://www.ncbi.nlm.nih.gov/pubmed/30655206 http://dx.doi.org/10.1016/j.ebiom.2018.11.045

Ejemplares similares

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2022)

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2016)

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2023)

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
por: Kanlikilicer, Pinar, et al.
Publicado: (2018)

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
por: Kanlikilicer, Pinar, et al.
Publicado: (2020)

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs
por: Rashed, Mohammed H, et al.
Publicado: (2017)

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
por: Dasari, Santosh K., et al.
Publicado: (2023)

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer
por: Gorur, Aysegul, et al.
Publicado: (2021)

Association of PTGER4 and PRKAA1 genetic polymorphisms with gastric cancer
por: Yu, Shuyong, et al.
Publicado: (2023)

PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11β-hydroxysteroid dehydrogenase activity by prostaglandin E(2) in human granulosa–lutein cells
por: Chandras, C, et al.
Publicado: (2007)

Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2017)

Maternal and Fetal Genetic Associations of PTGER3 and PON1 with Preterm Birth
por: Ryckman, Kelli K., et al.
Publicado: (2010)

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021)

Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2023)

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
por: Lara, Olivia D., et al.
Publicado: (2020)

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
por: Bayraktar, Emine, et al.
Publicado: (2023)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
por: Kanlikilicer, Pinar, et al.
Publicado: (2017)

Maternal Protein Restriction Alters the Renal Ptger1 DNA Methylation State in SHRSP Offspring
por: Miyoshi, Moe, et al.
Publicado: (2018)

Alternatively spliced isoforms of the human elk-1 mRNA within the 5′ UTR: implications for ELK-1 expression
por: Araud, Tanguy, et al.
Publicado: (2007)

HPV-18 E7 Interacts with Elk-1 Leading to Elevation of the Transcriptional Activity of Elk-1 in Cervical Cancer
por: Go, Sung-Ho, et al.
Publicado: (2022)

Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis
por: Ozen, Gulsen, et al.
Publicado: (2017)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2
por: Rytelewski, Mateusz, et al.
Publicado: (2016)

ELKS1 helps neuronal synapses diversify
por: Short, Ben
Publicado: (2017)

SENP1 participates in the dynamic regulation of Elk-1 SUMOylation
por: Witty, James, et al.
Publicado: (2010)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

The Epigenetic Legacy of Maternal Protein Restriction: Renal Ptger1 DNA Methylation Changes in Hypertensive Rat Offspring
por: Jia, Huijuan, et al.
Publicado: (2023)

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
por: Mangala, Lingegowda S., et al.
Publicado: (2021)

SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1
por: Salinas, Sara, et al.
Publicado: (2004)

ERK Signaling Controls Innate-like CD8(+) T Cell Differentiation via the ELK4 (SAP-1) and ELK1 Transcription Factors
por: Maurice, Diane, et al.
Publicado: (2018)

Prostaglandin E(2) Signals Through PTGER2 to Regulate Sclerostin Expression
por: Genetos, Damian C., et al.
Publicado: (2011)

Mapping PTGERs to the Ovulatory Follicle: Regional Responses to the Ovulatory PGE2 Signal
por: Kim, Soon Ok, et al.
Publicado: (2016)

Sequential activation of Elk-1/Egr-1/GADD45α by arsenic
por: Shi, Qiwen, et al.
Publicado: (2014)

MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma
por: Ranjan, Atul, et al.
Publicado: (2018)

Elk-1 a Transcription Factor with Multiple Facets in the Brain
por: Besnard, Antoine, et al.
Publicado: (2011)

Commentary: Antidepressive effects of targeting ELK-1 signal transduction
por: Cho, Chang-Hoon
Publicado: (2018)

NR5A2/LRH-1 regulates the PTGS2-PGE(2)-PTGER1 pathway contributing to pancreatic islet survival and function
por: Martin Vázquez, Eugenia, et al.
Publicado: (2022)

CTNNAL1 deficiency suppresses CFTR expression in HDM-induced asthma mouse model through ROCK1-CAL signaling pathway: CTNNAL1 increases CFTR expression in asthma mouse model
por: Wu, Di, et al.
Publicado: (2023)

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
por: Elsayed, Abdelrahman M., et al.
Publicado: (2021)

JARID1A, JMY, and PTGER4 Polymorphisms Are Related to Ankylosing Spondylitis in Chinese Han Patients: A Case-Control Study
por: Chai, Wei, et al.
Publicado: (2013)

EGF activates TTP expression by activation of ELK-1 and EGR-1 transcription factors
por: Florkowska, Magdalena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_387neticl3ovco416ufil27rei